[
  {
    "ts": null,
    "headline": "Eli Lilly and Company (LLY) CEO Dave Ricks presents at 43rd Annual J.P. Morgan Healthcare Conference (Transcript)",
    "summary": "Eli Lilly and Company (NYSE:LLY) 43rd Annual J.P. Morgan Healthcare Conference January 14, 2025 5:15 PM ETCompany ParticipantsDave Ricks - Chairman and...",
    "url": "https://finnhub.io/api/news?id=2554ff90da6864f77bd30b3159f80082fad5bdec9ce5609f4571a3dfc3bf0101",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1736884711,
      "headline": "Eli Lilly and Company (LLY) CEO Dave Ricks presents at 43rd Annual J.P. Morgan Healthcare Conference (Transcript)",
      "id": 132396605,
      "image": "https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png",
      "related": "LLY",
      "source": "SeekingAlpha",
      "summary": "Eli Lilly and Company (NYSE:LLY) 43rd Annual J.P. Morgan Healthcare Conference January 14, 2025 5:15 PM ETCompany ParticipantsDave Ricks - Chairman and...",
      "url": "https://finnhub.io/api/news?id=2554ff90da6864f77bd30b3159f80082fad5bdec9ce5609f4571a3dfc3bf0101"
    }
  },
  {
    "ts": null,
    "headline": "Health Care Slides After Lilly Warning - Health Care Roundup",
    "summary": "Health Care Slides After Lilly Warning - Health Care Roundup",
    "url": "https://finnhub.io/api/news?id=ccfac144068e0a9f5aa1d76f39dbbffcfa774130a4b8d4f1ecb928a90aa4b7dc",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1736874960,
      "headline": "Health Care Slides After Lilly Warning - Health Care Roundup",
      "id": 132407704,
      "image": "",
      "related": "LLY",
      "source": "MarketWatch",
      "summary": "Health Care Slides After Lilly Warning - Health Care Roundup",
      "url": "https://finnhub.io/api/news?id=ccfac144068e0a9f5aa1d76f39dbbffcfa774130a4b8d4f1ecb928a90aa4b7dc"
    }
  },
  {
    "ts": null,
    "headline": "Eli Lilly & Co. stock underperforms Tuesday when compared to competitors",
    "summary": "Eli Lilly & Co. stock underperforms Tuesday when compared to competitors",
    "url": "https://finnhub.io/api/news?id=2a8a6f884a735e3343300b46471c46457a65be5ec81355599a5739fce8d971c9",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1736872260,
      "headline": "Eli Lilly & Co. stock underperforms Tuesday when compared to competitors",
      "id": 132407705,
      "image": "",
      "related": "LLY",
      "source": "MarketWatch",
      "summary": "Eli Lilly & Co. stock underperforms Tuesday when compared to competitors",
      "url": "https://finnhub.io/api/news?id=2a8a6f884a735e3343300b46471c46457a65be5ec81355599a5739fce8d971c9"
    }
  },
  {
    "ts": null,
    "headline": "These Stocks Moved the Most Today: Palantir, Nvidia, Eli Lilly, Boeing, KB Home, Signet, Aehr, and More",
    "summary": "These Stocks Moved the Most Today: Palantir, Nvidia, Eli Lilly, Boeing, KB Home, Signet, Aehr, and More",
    "url": "https://finnhub.io/api/news?id=b26aa839f40a2f2c7e0669651cdb2fdae897d114f27df535c7f2fc81501290ff",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1736871720,
      "headline": "These Stocks Moved the Most Today: Palantir, Nvidia, Eli Lilly, Boeing, KB Home, Signet, Aehr, and More",
      "id": 132407706,
      "image": "",
      "related": "LLY",
      "source": "MarketWatch",
      "summary": "These Stocks Moved the Most Today: Palantir, Nvidia, Eli Lilly, Boeing, KB Home, Signet, Aehr, and More",
      "url": "https://finnhub.io/api/news?id=b26aa839f40a2f2c7e0669651cdb2fdae897d114f27df535c7f2fc81501290ff"
    }
  },
  {
    "ts": null,
    "headline": "Stock market today: Wall Street mostly rises after encouraging inflation data despite Lilly's drag",
    "summary": "NEW YORK — Most U.S. stocks rose Tuesday following an encouraging update on inflation, though drops for Eli Lilly and other influential stocks kept indexes in check. The S&P 500 rose 0.1% as...",
    "url": "https://finnhub.io/api/news?id=7b09b20eb3fa61a196e978a1a5af98219ba401c377065d57a839641c1f0ca90c",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1736871501,
      "headline": "Stock market today: Wall Street mostly rises after encouraging inflation data despite Lilly's drag",
      "id": 132395729,
      "image": "",
      "related": "LLY",
      "source": "Finnhub",
      "summary": "NEW YORK — Most U.S. stocks rose Tuesday following an encouraging update on inflation, though drops for Eli Lilly and other influential stocks kept indexes in check. The S&P 500 rose 0.1% as...",
      "url": "https://finnhub.io/api/news?id=7b09b20eb3fa61a196e978a1a5af98219ba401c377065d57a839641c1f0ca90c"
    }
  },
  {
    "ts": null,
    "headline": "Wall Street Lunch: Microsoft Is The Agentic AI Favorite",
    "summary": "Morgan Stanley CIO survey says Agentic AI is underappreciated. Wholesale inflation comes cool, but markets are wary. Meta to fire 5% of 'underperformers.'\"",
    "url": "https://finnhub.io/api/news?id=0db19cd79ab280ab9b38abf3a6f24c563dda5ebedf9f37fb3a466ab7902ead1c",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1736870460,
      "headline": "Wall Street Lunch: Microsoft Is The Agentic AI Favorite",
      "id": 132395745,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1729779122/image_1729779122.jpg?io=getty-c-w1536",
      "related": "LLY",
      "source": "SeekingAlpha",
      "summary": "Morgan Stanley CIO survey says Agentic AI is underappreciated. Wholesale inflation comes cool, but markets are wary. Meta to fire 5% of 'underperformers.'\"",
      "url": "https://finnhub.io/api/news?id=0db19cd79ab280ab9b38abf3a6f24c563dda5ebedf9f37fb3a466ab7902ead1c"
    }
  },
  {
    "ts": null,
    "headline": "Lilly's stock leads S&P 500 losers as Mounjaro, Zepbound sales to miss forecasts",
    "summary": "Lilly's stock leads S&P 500 losers as Mounjaro, Zepbound sales to miss forecasts",
    "url": "https://finnhub.io/api/news?id=7023f4d04c0dd9fcc49bfe7ae1b8b7d8e802ffd9bdc6318bdfa52802fa8137ff",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1736870028,
      "headline": "Lilly's stock leads S&P 500 losers as Mounjaro, Zepbound sales to miss forecasts",
      "id": 132407707,
      "image": "",
      "related": "LLY",
      "source": "MarketWatch",
      "summary": "Lilly's stock leads S&P 500 losers as Mounjaro, Zepbound sales to miss forecasts",
      "url": "https://finnhub.io/api/news?id=7023f4d04c0dd9fcc49bfe7ae1b8b7d8e802ffd9bdc6318bdfa52802fa8137ff"
    }
  },
  {
    "ts": null,
    "headline": "Stock market today: Most of Wall Street rises following encouraging inflation data, but Lilly drags",
    "summary": "NEW YORK — Most U.S. stocks are rising Tuesday following an encouraging update on inflation, but drops for Eli Lilly and some other influential stocks are keeping indexes in check. The S&P 500...",
    "url": "https://finnhub.io/api/news?id=3be0fa6cba42e70849db53c28c65cd19a20a2b5c8501dbad70b96ed7ceedce10",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1736867495,
      "headline": "Stock market today: Most of Wall Street rises following encouraging inflation data, but Lilly drags",
      "id": 132395423,
      "image": "",
      "related": "LLY",
      "source": "Finnhub",
      "summary": "NEW YORK — Most U.S. stocks are rising Tuesday following an encouraging update on inflation, but drops for Eli Lilly and some other influential stocks are keeping indexes in check. The S&P 500...",
      "url": "https://finnhub.io/api/news?id=3be0fa6cba42e70849db53c28c65cd19a20a2b5c8501dbad70b96ed7ceedce10"
    }
  },
  {
    "ts": null,
    "headline": "Eli Lilly’s Zepbound and Mounjaro Sales Missed Estimates Again. The Wobble’s Looking Serious.",
    "summary": "Eli Lilly’s Zepbound and Mounjaro Sales Missed Estimates Again. The Wobble’s Looking Serious.",
    "url": "https://finnhub.io/api/news?id=21186b35025ba19e0f5f6fb6035399fa4e2c84e9acda587e4dad642fc0b59672",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1736866980,
      "headline": "Eli Lilly’s Zepbound and Mounjaro Sales Missed Estimates Again. The Wobble’s Looking Serious.",
      "id": 132407708,
      "image": "",
      "related": "LLY",
      "source": "MarketWatch",
      "summary": "Eli Lilly’s Zepbound and Mounjaro Sales Missed Estimates Again. The Wobble’s Looking Serious.",
      "url": "https://finnhub.io/api/news?id=21186b35025ba19e0f5f6fb6035399fa4e2c84e9acda587e4dad642fc0b59672"
    }
  },
  {
    "ts": null,
    "headline": "Lilly forecasts weak sales of weight-loss drug, shares slump",
    "summary": "STORY: Shares of Eli Lilly tumbled as much as 8% on Tuesday, after the company forecast weaker-than-expected fourth-quarter sales of its weight-loss drug Zepbound. The decline put the...",
    "url": "https://finnhub.io/api/news?id=f781a2310e451c9ffdca3ea9d659bef8866cdeb3781e071d2438136ef7f2e3d6",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1736860824,
      "headline": "Lilly forecasts weak sales of weight-loss drug, shares slump",
      "id": 132395076,
      "image": "",
      "related": "LLY",
      "source": "Finnhub",
      "summary": "STORY: Shares of Eli Lilly tumbled as much as 8% on Tuesday, after the company forecast weaker-than-expected fourth-quarter sales of its weight-loss drug Zepbound. The decline put the...",
      "url": "https://finnhub.io/api/news?id=f781a2310e451c9ffdca3ea9d659bef8866cdeb3781e071d2438136ef7f2e3d6"
    }
  },
  {
    "ts": null,
    "headline": "7 Investments To Avoid In 2025",
    "summary": "Seeking Alpha contributors highlight 2025 investment picks. See why this article challenges you to avoid certain investments that may underperform.",
    "url": "https://finnhub.io/api/news?id=46e1914519d62530a905f9211828fbd4b737cfa43d92e8f6bc2adcc8b8475a2b",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1736857601,
      "headline": "7 Investments To Avoid In 2025",
      "id": 132394844,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1266564675/image_1266564675.jpg?io=getty-c-w1536",
      "related": "LLY",
      "source": "SeekingAlpha",
      "summary": "Seeking Alpha contributors highlight 2025 investment picks. See why this article challenges you to avoid certain investments that may underperform.",
      "url": "https://finnhub.io/api/news?id=46e1914519d62530a905f9211828fbd4b737cfa43d92e8f6bc2adcc8b8475a2b"
    }
  },
  {
    "ts": null,
    "headline": "Stock market today: Drops for Lilly and Big Tech weigh on Wall Street, even as most stocks rise",
    "summary": "NEW YORK — Drops for Eli Lilly and other influential companies are weighing on U.S. indexes Tuesday, even though most of the market is rising following an encouraging update on inflation. The S&P...",
    "url": "https://finnhub.io/api/news?id=683d0257dd0310709b8fe1fe217f5c585bdbfe51bf44945cb6a406b1e3b8f835",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1736856242,
      "headline": "Stock market today: Drops for Lilly and Big Tech weigh on Wall Street, even as most stocks rise",
      "id": 132394674,
      "image": "",
      "related": "LLY",
      "source": "Finnhub",
      "summary": "NEW YORK — Drops for Eli Lilly and other influential companies are weighing on U.S. indexes Tuesday, even though most of the market is rising following an encouraging update on inflation. The S&P...",
      "url": "https://finnhub.io/api/news?id=683d0257dd0310709b8fe1fe217f5c585bdbfe51bf44945cb6a406b1e3b8f835"
    }
  },
  {
    "ts": null,
    "headline": "Eli Lilly Tumbles On Lowered Guidance As Weight-Loss Drug Sales Slow",
    "summary": "Eli Lilly Tumbles On Lowered Guidance As Weight-Loss Drug Sales Slow",
    "url": "https://finnhub.io/api/news?id=04024b913b0483947272b49168b4616a0adcf2a9a659406bdd97d6385ba5a4d0",
    "source": "DowJones",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1736853907,
      "headline": "Eli Lilly Tumbles On Lowered Guidance As Weight-Loss Drug Sales Slow",
      "id": 132407686,
      "image": "",
      "related": "LLY",
      "source": "DowJones",
      "summary": "Eli Lilly Tumbles On Lowered Guidance As Weight-Loss Drug Sales Slow",
      "url": "https://finnhub.io/api/news?id=04024b913b0483947272b49168b4616a0adcf2a9a659406bdd97d6385ba5a4d0"
    }
  },
  {
    "ts": null,
    "headline": "Stock market today: Wall Street ticks higher after encouraging inflation data",
    "summary": "NEW YORK — Most U.S. stocks are rising on Tuesday following an encouraging update on inflation, but drops for Eli Lilly and some other influential companies are keeping indexes in check. The S&P...",
    "url": "https://finnhub.io/api/news?id=ef8233ad18026b3e9593754d3801d74ae5732fb2b82f6828157645c686267f56",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1736852646,
      "headline": "Stock market today: Wall Street ticks higher after encouraging inflation data",
      "id": 132394418,
      "image": "",
      "related": "LLY",
      "source": "Finnhub",
      "summary": "NEW YORK — Most U.S. stocks are rising on Tuesday following an encouraging update on inflation, but drops for Eli Lilly and some other influential companies are keeping indexes in check. The S&P...",
      "url": "https://finnhub.io/api/news?id=ef8233ad18026b3e9593754d3801d74ae5732fb2b82f6828157645c686267f56"
    }
  },
  {
    "ts": null,
    "headline": "Correction Eli Lilly Outlook Article",
    "summary": "The Indianapolis-based pharmaceutical company said it expects fourth-quarter revenue of $13.5 billion, around $400 million below the low end of its last estimated range issued in October. Eli Lilly...",
    "url": "https://finnhub.io/api/news?id=b0dab12e5ddbe8a44d153a22e963a6d3d26b0b2fcd0f63b67f550f80c8e7decc",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1736851692,
      "headline": "Correction Eli Lilly Outlook Article",
      "id": 132394339,
      "image": "",
      "related": "LLY",
      "source": "Finnhub",
      "summary": "The Indianapolis-based pharmaceutical company said it expects fourth-quarter revenue of $13.5 billion, around $400 million below the low end of its last estimated range issued in October. Eli Lilly...",
      "url": "https://finnhub.io/api/news?id=b0dab12e5ddbe8a44d153a22e963a6d3d26b0b2fcd0f63b67f550f80c8e7decc"
    }
  },
  {
    "ts": null,
    "headline": "Eli Lilly Cuts Sales Outlook After Sluggish Growth for Incretin Drugs",
    "summary": "Eli Lilly Cuts Sales Outlook After Sluggish Growth for Incretin Drugs",
    "url": "https://finnhub.io/api/news?id=4b2c2da58e5e959ba56193af90c80fa786648da6e21f1cae0c95e7e0d8c44a59",
    "source": "DowJones",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1736851200,
      "headline": "Eli Lilly Cuts Sales Outlook After Sluggish Growth for Incretin Drugs",
      "id": 132407687,
      "image": "",
      "related": "LLY",
      "source": "DowJones",
      "summary": "Eli Lilly Cuts Sales Outlook After Sluggish Growth for Incretin Drugs",
      "url": "https://finnhub.io/api/news?id=4b2c2da58e5e959ba56193af90c80fa786648da6e21f1cae0c95e7e0d8c44a59"
    }
  },
  {
    "ts": null,
    "headline": "Mounjaro and Zepbound sales disappoint, and Eli Lilly’s stock is dropping",
    "summary": "Mounjaro and Zepbound sales disappoint, and Eli Lilly’s stock is dropping",
    "url": "https://finnhub.io/api/news?id=20df8f709310a01468bf48e9ea02dd8a2a9873d83e415c7218c2fa505bc90a90",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1736850000,
      "headline": "Mounjaro and Zepbound sales disappoint, and Eli Lilly’s stock is dropping",
      "id": 132407709,
      "image": "",
      "related": "LLY",
      "source": "MarketWatch",
      "summary": "Mounjaro and Zepbound sales disappoint, and Eli Lilly’s stock is dropping",
      "url": "https://finnhub.io/api/news?id=20df8f709310a01468bf48e9ea02dd8a2a9873d83e415c7218c2fa505bc90a90"
    }
  },
  {
    "ts": null,
    "headline": "Eli Lilly Cuts 4Q Sales Outlook After Sluggish Growth for Incretin Drugs",
    "summary": "By Owen Tucker-Smith Eli Lilly cut its outlook for fourth-quarter revenue as the market for drugs that increase insulin levels grew slower than expected, but the company sees healthy growth in...",
    "url": "https://finnhub.io/api/news?id=7d5159a81dce959a93d3456f651c32677a304d3ea727f30e14ab64f6d63cc86d",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1736849234,
      "headline": "Eli Lilly Cuts 4Q Sales Outlook After Sluggish Growth for Incretin Drugs",
      "id": 132394156,
      "image": "",
      "related": "LLY",
      "source": "Finnhub",
      "summary": "By Owen Tucker-Smith Eli Lilly cut its outlook for fourth-quarter revenue as the market for drugs that increase insulin levels grew slower than expected, but the company sees healthy growth in...",
      "url": "https://finnhub.io/api/news?id=7d5159a81dce959a93d3456f651c32677a304d3ea727f30e14ab64f6d63cc86d"
    }
  },
  {
    "ts": null,
    "headline": "Lilly forecasts weak sales of weight-loss drug in fourth quarter",
    "summary": "Eli Lilly expects sales of popular weight-loss drug Zepbound and related diabetes treatment Mounjaro to miss Wall Street expectations in the fourth quarter, but forecast 2025 revenue largely above...",
    "url": "https://finnhub.io/api/news?id=a5055b1dc0c2f521c0b326254e4fff4fc20bc8b6858b919909d662a02706a38a",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1736847195,
      "headline": "Lilly forecasts weak sales of weight-loss drug in fourth quarter",
      "id": 132393992,
      "image": "",
      "related": "LLY",
      "source": "Finnhub",
      "summary": "Eli Lilly expects sales of popular weight-loss drug Zepbound and related diabetes treatment Mounjaro to miss Wall Street expectations in the fourth quarter, but forecast 2025 revenue largely above...",
      "url": "https://finnhub.io/api/news?id=a5055b1dc0c2f521c0b326254e4fff4fc20bc8b6858b919909d662a02706a38a"
    }
  },
  {
    "ts": null,
    "headline": "Eli Lilly: unveils its 2024 forecasts and 2025 ambitions",
    "summary": "Eli Lilly forecasts worldwide sales for 2024 of around $45 billion, up 32% on the previous year. For the fourth quarter of 2024, Lilly forecasts worldwide sales of around $13.5 billion, up 45% on the...",
    "url": "https://finnhub.io/api/news?id=6b12996099a49aa95809f3ff1e9d615d7536a1672ec9bd2d329fe73b27dcf0d1",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1736846833,
      "headline": "Eli Lilly: unveils its 2024 forecasts and 2025 ambitions",
      "id": 132393951,
      "image": "",
      "related": "LLY",
      "source": "Finnhub",
      "summary": "Eli Lilly forecasts worldwide sales for 2024 of around $45 billion, up 32% on the previous year. For the fourth quarter of 2024, Lilly forecasts worldwide sales of around $13.5 billion, up 45% on the...",
      "url": "https://finnhub.io/api/news?id=6b12996099a49aa95809f3ff1e9d615d7536a1672ec9bd2d329fe73b27dcf0d1"
    }
  },
  {
    "ts": null,
    "headline": "Lilly provides update on 2024 revenue guidance, announces 2025 revenue guidance",
    "summary": "2024 revenue is expected to be approximately $45.0 billion for the full year, $4.0 billion above the midpoint of first-time 2024 financial guidanceQ4 2024 revenue is expected to be approximately...",
    "url": "https://finnhub.io/api/news?id=78613b2ed4d273bbc13ba4fa1c41e359611784e99988d206ad9000d3790df465",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1736845274,
      "headline": "Lilly provides update on 2024 revenue guidance, announces 2025 revenue guidance",
      "id": 132393773,
      "image": "",
      "related": "LLY",
      "source": "Finnhub",
      "summary": "2024 revenue is expected to be approximately $45.0 billion for the full year, $4.0 billion above the midpoint of first-time 2024 financial guidanceQ4 2024 revenue is expected to be approximately...",
      "url": "https://finnhub.io/api/news?id=78613b2ed4d273bbc13ba4fa1c41e359611784e99988d206ad9000d3790df465"
    }
  }
]